Sirolimus as a Dual Immunosuppressant and Antitumor Agent for Kaposi's Sarcoma in Renal-Transplant Recipients

A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma

Conditions : Epithelioid Hemangioendothelioma Interventions : Drug: Sirolimus for injection (Albumin-bound) Sponsors : CSPC ZhongQi Pharmace

Europa resucita la 'fórmula Covid' para evaluar el fármaco llamado a revolucionar el cáncer de páncreas

La 'revisión por etapas' permite acelerar el tiempo hasta la aprobación. Daraxonrasib ha duplicado la supervivencia al tumor en ensayos clín

SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial

Conditions : Kidney Transplant Recipient; Sodium Glucose Co-Transporter 2 Inhibitors; Non-Diabetic Patients; Randomized Controlled Trial (RC

Cancer and immunosuppression identified as key drivers of non-HIV PJP risk

Patients with haematological cancers and those receiving high-dose corticosteroids are at substantially increased risk of developing Pneumoc

Odds of HPV-Related Cancers Up for People With HIV, Solid Organ Transplant Recipients

A New Class of Therapeutics Could End Immunosuppressants

Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant